ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
ASAIO 2025 | Impella 5.5 Is Safe in Small Ventricles
In June 2025, the American Society for Artificial Internal Organs assembled leading cardiothoracic surgeons to share insights and expertise on advanced topics in cardiothoracic surgery Watch for more ASAIO 2025 videos in the coming weeks.
At the American Society for Artificial Internal Organs (ASAIO) 2025 Annual Conference, Dr. Andrew M. Acker, a cardiothoracic surgery resident at Penn Medicine, delivered a presentation titled “Impella 5.5 Is Safe in Small Ventricles.”
Dr. Acker provided a thorough overview of the study’s background, as well as the history of the Impella 5.5. Additionally, he discussed the study’s methods, including the primary and secondary outcomes, and the results from the study. Furthermore, he highlighted the rates of complications and rates of death.
Disclaimer
The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.
Printer-friendly
